DraftKings: MACD Death Cross and KDJ Death Cross Triggered in 15min Chart

DraftKings's 15-minute chart has exhibited a significant downturn, as evidenced by the occurrence of a MACD Death Cross and KDJ Death Cross at 09/03/2025 15:15. This suggests that the stock's price momentum has shifted towards the downside, potentially leading to further decreases in the stock's value.

DraftKings' (NASDAQ: DKNG) stock has shown significant downward momentum, as indicated by the occurrence of a MACD Death Cross and KDJ Death Cross on its 15-minute chart at 09/03/2025 15:15. These technical indicators suggest a potential continuation of the downward trend, with momentum shifting towards further decreases in the stock's value.

According to the 15-minute chart for DraftKings, both the MACD and KDJ indicators crossed below their respective thresholds on August 29, 2023, at 09:45 [1]. This indicates that the stock price has the potential to continue falling, as the momentum of the stock price is shifting towards the downside and has the potential to further decrease.

ARK ETFs, managed by Cathie Wood, have shown significant activity in biotech and tech stocks over the past week. On Tuesday, August 26, 2025, the ARKK ETF reported substantial trades, with notable purchases and sales in various companies [2]. One of the largest trades of the day was the acquisition of 165,874 shares of CRISPR Therapeutics AG (NASDAQ: CRSP), valued at approximately $8.98 million. This purchase reflects ARK's bullish stance on the gene-editing company. Additionally, ARKK bought shares of Intellia Therapeutics Inc. (NASDAQ: NTLA), purchasing 191,705 shares for around $2.18 million, indicating a strong conviction in the gene-editing space [1].

On the selling side, ARK offloaded a substantial number of shares in DraftKings Inc. (NASDAQ: DKNG) and Roku Inc. (NASDAQ: ROKU), with sales amounting to $6.04 million and $6.61 million, respectively. These sales continue a pattern of reduction, particularly for Roku, which ARK has been selling consistently over the past week. Smaller sales were also made in Coinbase Global Inc. (NASDAQ: COIN) and Shopify Inc. (NYSE: SHOP), valued at approximately $597,312 and $588,680, respectively [1].

Investors following ARK’s movements will note the ETF’s strategic shifts. ARK is increasing positions in biotech companies specializing in CRISPR technology while reducing holdings in specific tech and entertainment companies. These trades reflect ARK’s ongoing strategy to capitalize on disruptive innovation and technology in various sectors.

Price T Rowe Associates Inc. MD has reduced its stake in DraftKings Inc. by 4.3%, selling 61,059 shares and now holding 1,348,175 shares worth approximately $44.77 million [2]. DraftKings reported a positive earnings surprise in their latest earnings report, with $0.30 earnings per share against an expected $0.16, and quarterly revenue of $1.51 billion. Price T Rowe Associates Inc. MD lowered its stake in DraftKings Inc. (NASDAQ: DKNG - Free Report) by 4.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,348,175 shares of the company's stock after selling 61,059 shares during the period [2].

DraftKings Inc. (NASDAQ: DKNG - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.16 by $0.14. DraftKings had a negative return on equity of 30.06% and a negative net margin of 5.63%. The business had revenue of $1.51 billion during the quarter, compared to analysts' expectations of $1.39 billion. During the same quarter last year, the firm posted $0.12 earnings per share. The firm's revenue was up 36.9% on a year-over-year basis. DraftKings has set its FY 2025 guidance at EPS. On average, equities analysts forecast that DraftKings Inc. will post 0.64 EPS for the current fiscal year [2].

In other DraftKings news, CFO Alan Wayne Ellingson sold 44,693 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $44.90, for a total value of $2,006,715.70. Following the completion of the sale, the chief financial officer owned 128,131 shares of the company's stock, valued at approximately $5,753,081.90. This trade represents a 25.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink [2]. Also, Director Ryan R. Moore sold 76,390 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $45.92, for a total value of $3,507,828.80. Following the completion of the sale, the director directly owned 402 shares of the company's stock, valued at $18,459.84. This trade represents a 99.48% decrease in their position. The disclosure for this sale can be found here [2]. In the last ninety days, insiders have sold 711,108 shares of company stock valued at $30,460,181. Company insiders own 51.19% of the company's stock [2].

A number of equities analysts have issued reports on the company. Stifel Nicolaus lowered their target price on DraftKings from $53.00 to $51.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft set a $47.00 price target on DraftKings and gave the company a "hold" rating in a research note on Friday, August 8th. Wall Street Zen cut DraftKings from a "buy" rating to a "hold" rating in a research note on Saturday. Jefferies Financial Group set a $54.00 price target on DraftKings in a research note on Thursday, August 21st. Finally, Morgan Stanley reissued an "overweight" rating and issued a $52.00 price target (up previously from $51.00) on shares of DraftKings in a research note on Friday, July 11th. Twenty-five analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $54.50 [2].

DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. It provides online sports betting and casino, daily fantasy sports, media, and other consumer products, as well as retails sportsbooks. The company also engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators [2].

References:
[1] https://www.investing.com/news/company-news/cathie-woods-ark-buys-crispr-sells-roku-and-draftkings-stock-93CH-4211799
[2] https://www.marketbeat.com/instant-alerts/filing-price-t-rowe-associates-inc-md-sells-61059-shares-of-draftkings-inc-dkng-2025-08-28/